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Background: A cross-sectional survey was performed to estimate the prevalence of periportal 23 
fibrosis in children based on ultrasound examination in the Marolambo District of the 24 
Atsinanana Region of Madagascar.  This is a remote area known to have a high prevalence 25 
of intestinal schistosomiasis. 26 
 27 
Methods: School-aged children (5-14 years) were selected from six villages for parasitological 28 
and sonographic examination. Circulating cathodic antigen (CCA) tests and Kato Katz (KK) 29 
stool microscopy were performed. Video clips of liver views were recorded with a SonoSite i-30 
Viz and interpreted in the UK by comparison with standardised images (WHO protocol). 31 
 32 
Results: The prevalence of schistosomiasis according to CCA testing was 97.8% (269/275) 33 
and 73.8% (203/275) by KK. Sonographic evidence of periportal fibrosis was observed in 34 
11.3% (31/275). The youngest children with fibrosis were six years old. Fibrosis was more 35 
common in older children (p=0.03) but was not associated with infection intensity category 36 
(p=0.07) or gender (p=0.67). 37 
 38 
Conclusions: Findings of periportal fibrosis amongst children in these hard-to-reach villages 39 
suggests chronic Schistosoma mansoni infection from a very young age.  This may reflect 40 
other similarly remote schistosomiasis-endemic areas and reinforces the need to investigate 41 
morbidity in neglected communities in order to understand the true extent of disease burden 42 
in endemic countries. 43 
 44 







Schistosomiasis is a parasitic disease associated with significant morbidity.1 It is 51 
estimated that at least 230 million people are infected with Schistosoma species globally, with 52 
an associated loss of 3 – 70 million disability-adjusted life years.2 Infection with Schistosoma 53 
mansoni causes intestinal and hepatosplenic disease as the parasites’ eggs lodge in tissue 54 
causing inflammation and fibrosis. Symptoms include diarrhoea, abdominal discomfort and 55 
blood in the stool. Hepatic periportal fibrosis can result in portal hypertension and gastro-56 
oesophageal varices which can be fatal upon variceal rupture.1 Repeated chemotherapy with 57 
praziquantel can lead to reversal of periportal fibrosis3,4 through action on existing egg 58 
granulomas and by halting further egg deposition. 5 59 
The first step towards elimination of schistosomiasis is morbidity control by mass 60 
treatment with praziquantel alongside complimentary public health interventions.6 Ultrasound 61 
examination allows visualisation of hepato-splenic complications of S. mansoni infection and 62 
is recommended as an indicator of schistosomiasis-related morbidity.7  63 
Establishing the geographical distribution of schistosomiasis, associated morbidity and 64 
the impact of treatment interventions remains priority.6,8 Ultrasound examination is 65 
recommended as an important part of control programmes by regular examination of sentinel 66 
groups to monitor morbidity and response to treatment.4,7  67 
The WHO protocol for sonographic examination of schistosomiasis-related morbidity7 68 
appears to be the most widely used.9 It aims to provide a standardised protocol to facilitate 69 
comparison of results between different surveys around the world.7 Although there are many 70 
of causes of hepatomegaly and portal hypertension (complications of S. mansoni infection), 71 
the distinctive pattern of periportal fibrosis seen with ultrasound is characteristic of S. mansoni 72 
infection. Diagnosis of schistosomiasis-related hepatic disease can therefore be differentiated 73 
from other hepatic pathology with ultrasound.10 74 
Performing ultrasound in many remote, endemic areas remains very challenging due 75 
to difficult access, lack of electrical power sources and lack of human resources (particularly 76 
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experienced ultrasound operators). Owing to these challenges, indirect indicators of morbidity 77 
are often used for monitoring.  For example, the World Health Organisation (WHO) gives a 78 
morbidity control target of <5% prevalence of heavy-intensity infections (≥ 400 eggs per gram 79 
of stool).6 80 
In Madagascar, schistosomiasis is endemic in 107 of the 114 districts.11 In the 81 
Marolambo District in 2015, the prevalence of S. mansoni infection in school-aged children 82 
(SAC) was 94%. A third of these children were found to have heavy-intensity infections. The 83 
district is not endemic for S. haematobium.12,13 These parasitological findings in 2015 84 
prompted annual mass treatment with praziquantel for SAC in the district, organised by the 85 
Ministry of Health in Madagascar. However, no data were collected on hepatic morbidity.   86 
The aim of this epidemiological survey was to determine the prevalence of periportal 87 
fibrosis amongst a sample of SAC in this very remote area, hyperendemic for schistosomiasis. 88 
This study was organised by Madagascar Medical Expeditions (MadEx), a voluntary research 89 
organisation set up by students at The University of Manchester, UK. 90 
 91 
Methods 92 
Study design and population 93 
This cross-sectional study took place in 2016 (May - June) in six villages lying along 94 
the Nosivolo River in the Marolambo District of the Atsinanana Region in East Madagascar; 95 
Marolambo, Ampasimbola, Ambohitelo, Marofatsy, Vohidamba and Betampona. These were 96 
the only villages in the district that could be included due to warnings from local authorities 97 
that the team’s safety could not be guaranteed beyond these locations. Relationships had 98 
already been formed with local community leaders and local organisations in these villages 99 
during a MadEx study in 2015;12 this ongoing support was essential to carry out research in a 100 
setting such as this.   101 
Communities in the Marolambo District rely heavily on environmental water for 102 
drinking, cooking, washing and transport. Outside the main village of Marolambo, there is no 103 
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access to electrical power.  Access to the villages upstream of Marolambo is via a single-track 104 
footpath which is impassable at certain times of the rainy season.   105 
There are very few known data recorded that give an indication of sociodemographic 106 
characteristics of these communities.  However, it is reported that around 95% of the 107 
population are farmers. 108 
The entire school register in each village was stratified by age and gender.  All pupils 109 
in the register were numbered and fifty children per village were selected by random with an 110 
even spread across gender and age (5 – 14 years). After gaining parental consent, children 111 
were invited to participate in the study.  A total sample size of 300 SAC was chosen as the 112 
limit that would be practicably possible to include (constrained by availability of time, funds 113 
and human resources).  Upon inclusion, each child was assigned a unique identifiable 114 
number. 115 
Praziquantel was administered to school-aged children in all six villages in 2015 but 116 
prior to this there had been no mass treatment since 2008. It was not possible to accurately 117 
know which study participants received treatment in 2015 as records were not available.   118 
 119 
Parasitological examination 120 
Each participant was given two sample containers (pre-labelled with unique identifiable 121 
numbers) and asked to provide a urine and a stool sample.   122 
A circulating cathodic antigen test (CCA; Rapid Medical Diagnostics Tests, Pretoria, 123 
South Africa) was performed within six hours of receipt of the urine samples.  Testing methods 124 
were in line with the manufacturer’s instructions and the results were read by two trained 125 
technicians to ensure homogeneity. Results were recorded as either positive (presence of test 126 
band) or negative (absence of test band). 127 
Two thick smears (containing 41.7mg of stool) were prepared from each stool sample 128 
using the Kato-Katz (KK; Vestergaard-Frandsen, Lausanne, Switzerland) method. Slides were 129 
prepared within six hours of receipt of the samples. Each slide was examined under light 130 
microscopy by one of four team members (with training and prior experience) to count, if 131 
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present, the number of Schistosoma mansoni eggs. The two slides from each sample were 132 
not interpreted by the same reader, and readers were blinded to the findings of others.  Results 133 
of the two slides were used to calculate the mean number of eggs per slide. From this, the 134 
total number of eggs per gram (epg) was determined for each child. 135 
Testing for S. haematobium was not performed as a cross-sectional study in these six 136 
villages in 2015 did not identify any S. haematobium infections in this area.12 Soil-transmitted 137 
helminths were not addressed in this study. 138 
 139 
Ultrasound examination 140 
An i-Viz (Fujifilm SonoSite, Inc.) portable ultrasound system with a phased array probe (5-141 
1MHz) was used. The operators were three senior medical students, trained by consultant 142 
radiologists in the UK to capture a predefined set of video-clips. The students were trained to 143 
obtain five-second video clips of the following views: longitudinal and transverse subcostal 144 
views of the left lobe, transverse and oblique subcostal and oblique intercostal views of the 145 
right lobe of the liver. These views were selected as they are listed in the WHO protocol.7 146 
Views of the spleen were not included due to the endemicity of malaria in the district, in line 147 
with the WHO protocol7. Once a good view was obtained at each of the sites, a video clip was 148 
recorded as the operator fanned through the view (from one extreme to the other) with the 149 
probe’s footprint otherwise stationary. Video clips were stored under each child’s unique 150 
identifiable number and exported to a USB drive.   151 
The children were asked to lie supine with their legs outstretched and examination took 152 
place in the presence of a chaperone. The children in each village were scanned 153 
opportunistically, in no particular order, by one of the three medical students (who each did an 154 
equal share of the scanning). 155 
 156 
Ultrasound interpretation 157 
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Interpretation of the ultrasound clips took place in the UK. A consultant radiologist 158 
(ECJ) and newly qualified doctor (HJR) interpreted the ultrasound clips of the first 15% of 159 
children together in order to train HJR. After this, HJR interpreted the remaining cases. 160 
Liver parenchyma were compared with standard image patterns included in an annex 161 
of the WHO protocol and assigned the letter it best aligned with. Image patterns A and B 162 
were considered normal, C-F corresponded to progressive degrees of periportal fibrosis, and 163 
Z was used for other abnormalities.7 Cases were only labelled with ‘image pattern C’ if there 164 
was clear thickening in the periphery of the parenchyma where portal branch walls should 165 
not normally be clearly visible with ultrasound.   166 
A random sample of the cases (10%) was second-read by the radiologist for quality 167 
assurance purposes. Interpreters were blinded to demographical and parasitological results. 168 
 169 
Health interventions and ethical considerations 170 
After the study, Malagasy members of the MadEx team delivered a schistosomiasis 171 
education programme in the schools. 172 
The study was timed to take place immediately before mass treatment of SAC in the 173 
district, delivered as part of the national schistosomiasis control programme.  A Ministry of 174 
Health official travelled to the villages with the MadEx team to coordinate mass treatment 175 
which took place in each village the day after testing finished.  Throughout the study, the 176 
participants and parents/guardians were repeatedly informed of the upcoming treatment 177 
programme, the importance of which was reinforced by the education programme.  At the end 178 
of testing, the names of schistosomiasis-positive children were shared with the health centre 179 
in their village (Centres de Santé de Base) to ensure that positive children had received 180 
treatment. 181 
The University of Manchester Research Ethics Committee (UREC3) approved 182 
the project (#16153). Research permits were granted by the Ministry of Health, 183 
Madagascar. Written consent for participation in the study was obtained from the child and 184 
their parent / guardian. All data were anonymised. 185 
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 186 
Data analysis 187 
Statistical analyses were performed using StataCorp 2017 (Stata Statistical Software 188 
15. College Station, TX: StataCorp LLC). The chi-squared test was used to assess the 189 
relationship between those diagnosed with schistosomiasis by either CCA or Kato Katz and 190 
those with and periportal fibrosis.  Ultrasound findings were compared to age, gender, 191 
infection intensity and village by multiple logistic regression analyses.   192 
 193 
Results 194 
Twenty-four (8.0%) cases were excluded due to missing data: two (0.7%) children did 195 
not attend on testing days at all, two (0.7%) children did not provide a stool sample, sixteen 196 
(5.3%) children declined or did not attend for an ultrasound scan, and the ages of four (1.3%) 197 
children were not recorded. One (0.3%) additional case was excluded as the recorded 198 
ultrasound clips were not interpretable. There were therefore 25 (8.3%) children excluded from 199 
the study. 200 
Of the 275 children included in the results of this study, 141 (51.3%) were female and 201 
134 (48.7%) were male. The number of children in the study by age and gender are listed in 202 
Table 1.  203 
 204 
Parasitological results 205 
The prevalence of egg-patent S. mansoni infection according to CCA testing was 206 
269/275 (97.8%) and 203/275 (73.8%) according to KK. The spread of low (1-99 epg), medium 207 
(100-399 epg) and heavy (≥400 epg) infection intensities according to KK technique was 208 
85/202 (42.1%), 66/202 (32.7%) and 51/202 (25.2%) respectively. For those with positive KK, 209 
median egg count was 144 epg (range 24-5040 epg). Neither age nor gender were associated 210 
with prevalence of S. mansoni infection by CCA (p=0.26, p=0.95, respectively) or KK (p=0.61, 211 
p=0.80, respectively; Table 1).  212 
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 213 
Ultrasound results 214 
Image patterns A, B and C were observed in 235/275 (85.5%), 8/275 (2.9%) and 215 
31/275 (11.3%) of cases respectively (see Figures A, B and C). An example of the ultrasound 216 
findings for a child without S. mansoni infection (negative CCA and KK testing) is shown for 217 
comparison in Figure D.  There were no cases of image patterns D, E or F.  One case was 218 
interpreted as Z. The youngest children with sonographic evidence of periportal fibrosis were 219 
six years old. The six children with negative CCA results had a sonographically normal liver 220 
parenchyma. Six KK-negative children were found to have sonographic evidence of fibrosis 221 
(Table 2). 222 
There was no evidence of an association between S. mansoni-positive cases detected 223 
by either CCA or Kato Katz, and sonographic evidence of periportal fibrosis (p=0.38, p=0.36 224 
respectively). The prevalence of periportal fibrosis amongst CCA-negative and CCA-positive 225 
children was 0/6 (0.0%) and 31/269 (11.5%) respectively.  The prevalence of periportal fibrosis 226 
amongst Kato Katz-negative and Kato Katz-positive children was 6/72 (8.3%) and 25/203 227 
(12.5%) respectively. 228 
The prevalence of children with periportal fibrosis increased with age (padj=0.03, ORadj 229 
1.17, 95%CI 1.02-1.34; see Table 1, Figure E). Gender was not linked to periportal fibrosis: of 230 
the 31 cases with pattern C, 17 (54.8%) were female and 14 (45.2%) were male (p=0.67; 231 
Table 1).  There was minimal evidence for an association between the prevalence of periportal 232 
fibrosis and infection intensity when categorised as low, moderate or heavy (padj=0.08, 233 
ORadj=1.38, 95%CI 0.96-1.97; Table 2).  Finally, there was no association between prevalence 234 
of sonographic periportal fibrosis and village (padj=0.19). 235 
 236 
Quality assurance of ultrasound interpretation 237 
The random sample (10%) second read by the radiologist matched with the initial 238 




Periportal fibrosis, a well-recognised complication of chronic S. mansoni infection, was 242 
detected in 11.3% of school-aged children in the Marolambo District, Madagascar. We 243 
observed evidence of periportal fibrosis in children as young as six years old. This reflects 244 
exposure to S. mansoni cercariae from a very young, preschool age in the absence of annual 245 
treatment programmes. Consistent with other studies, presence of periportal fibrosis in our 246 
study sample appears to be associated with chronicity of infection.14-19 Although no association 247 
was found between S. mansoni infection and periportal fibrosis, there was some suggestion 248 
that increasing infection intensities may be associated with periportal fibrosis.  249 
The remoteness of the communities we studied posed a logistical challenge and 250 
possibly explains why there had not been a schistosomiasis prevalence survey or morbidity 251 
monitoring performed since 1961 prior to MadEx investigation in 2015.12,13 The lack of 252 
contemporary prevalence data for the area has meant that the true need for treatment had not 253 
been recognised and may explain the infrequency of mass treatment programmes in the 254 
district.   255 
Schistosomiasis is hyperendemic in the six villages included in this study.  In addition 256 
to the lack of regular mass treatment, there are many reasons which may explain the high 257 
prevalence.  Although not the particular focus of this study, many observations have been 258 
made whilst working in this area. The communities are dependent on the Nosivolo River and 259 
its surrounding streams for drinking water, bathing, washing clothes and plates, and 260 
transportation.  Many community members (including children) also pan for gold in the river. 261 
The majority of the working population are farmers, and considerable time may be spent 262 
tending to rice paddies.  263 
Had it not been for the safety threat, we suspect that our research methods could have 264 
been applied in the district’s other villages. The kit was carried in rucksacks on foot, electrical 265 
equipment was charged by solar energy; the research methods can be reproduced in other 266 
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remote settings.  However, the team recognise that, as in this district, there may be 267 
uncontrollable barriers preventing studies from taking place in some remote settings.  268 
Periportal fibrosis has been demonstrated in preschool-aged children20 and school 269 
aged children in endemic countries.4,14-22 In a study in Western Zambia, ultrasound 270 
examination was performed, and liver image patterns were assigned by a trained sonographer 271 
in the field. Amongst 7-9-year olds and 10-14-year olds, the prevalence of liver fibrosis 272 
(according to WHO protocol’s image patterns C-F) was 14% (n=50) and 16.7% (n=96) 273 
respectively.7,16 In Tanzania, a study of 354 children between 6-17 years old, identified 274 
periportal fibrosis in 5.4% (n=354) of these children.21 In this study, the WHO protocol was 275 
performed by experienced observers. In contrast, periportal fibrosis was not detected at all in 276 
a population aged between 7 - 20 years in Kenya (88.5% of whom were excreting S. mansoni 277 
eggs).23 Ultrasound examination methods in this study again followed the WHO protocol and 278 
fibrosis was classified as image pattern C-F.    279 
Ultrasound has become relatively inexpensive and highly portable however, 280 
interpretation can be subject to interobserver variance.24 Measuring portal branch wall 281 
thickness (PBWT) is time consuming, requires a high skill level and can be nonspecific.  In a 282 
review of WHO protocol usage, PBWT was measured in 19/41 studies, and only 2 of these 283 
studies reported the results.9 Alternatively, assignment of an image pattern can be done 284 
rapidly and apparently with a good degree of reproducibility.9,19 In our study, we elected to 285 
focus solely on image patterns. We grouped image patterns A and B together as being ‘normal’ 286 
scans however, some cases of pattern B may actually reflect early stages of fibrotic change. 287 
Although the use of image patterns makes the assessment relatively simple, it can be 288 
challenging to fit cases into distinct categories, particularly in the context of early-stage 289 
fibrosis.  Before unequivocal fibrosis develops, the morphology of the liver lies somewhere 290 
between normal and abnormal.9 This is challenging stage to interpret with ultrasound, and the 291 
stage that we expect many of our study participants may well have been in.  To prevent 292 
overdiagnosis, we therefore ensured that, cases were only defined as abnormal when findings 293 




 Delivery of preventive chemotherapy to at-risk populations from an early age is key for 297 
preventing development of hepato-splenic complications.2 Our finding of fibrosis in children as 298 
young as six reinforces the need for praziquantel administration to preschool-aged children in 299 
order to halt (and hopefully reverse) periportal fibrosis. 300 
Great variation in hepatosplenic disease between neighbouring villages in 301 
Madagascar has been described suggesting that extrapolation of morbidity data to entire 302 
regions may not be accurate.25 This reinforces the need for high resolution morbidity mapping 303 
to fully understand disease burden in a region. Regular monitoring of schistosomiasis-related 304 
morbidity with ultrasound is recommended but there are many challenges to implementing 305 
this. 306 
There is a need for a quick, simple protocol that can be performed by relatively ‘novice’ 307 
(non-expert) operators with highly portable, solar-powered ultrasound systems. This may be 308 
achieved by assigning image patterns to clips from examinations which take less than two 309 
minutes per case. Such a rapid assessment might increase the number of community surveys 310 
that include ultrasound assessment alongside other morbidity tests, thus improving 311 
understanding of the geographical distribution of schistosomiasis and its burden. However, 312 
this abbreviated assessment should be tested against the full recommended WHO protocol to 313 
ensure its accuracy and reliability. 314 
We present a method of performing ultrasound examination in this challenging setting: 315 
video clips recorded by relatively novice ultrasound operators using highly portable, solar-316 
powered ultrasound devices and interpreted remotely.  We returned to the UK with ultrasound 317 
images for interpretation and recognise that this is not a sustainable approach for ultrasound 318 
use on a larger scale to monitor morbidity associated with schistosomiasis.  There are however 319 
possibilities to employ telemedicine to share images with central experts.  In our study, the 320 
images were recorded by medical students who were able to record adequate clips for 321 
interpretation. Further work is needed to investigate the skill level required to obtain adequate 322 
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images, and also to even interpret images.  If it is shown that minimal training is needed to 323 
assign image patterns accurately, perhaps ultrasound-based morbidity surveys could be 324 
carried out on a much larger scales by investigators requiring less training.  This would lead 325 
to better mapping of morbidity in countries endemic for schistosomiasis and would guide 326 
national control programmes. 327 
 328 
Limitations 329 
There are a number of limitations to our study. The sample was selected from the 330 
school register meaning that non-school-attending children were excluded from the study. 331 
School attendance is affected by severe schistosomiasis and therefore our sample of school-332 
attenders may be an underrepresentation of the true prevalence of periportal fibrosis in this 333 
area.26 The six villages involved in our study may not be representative of the whole district. 334 
There may also be observer bias; although interpreters were blinded to parasitological and 335 
demographical results, the high prevalence of schistosomiasis already known in the 336 
Marolambo District makes it difficult to avoid this bias. Unmeasured and unknown confounding 337 
factors may have influenced the results. Although sonographic evidence of periportal fibrosis 338 
is characteristic of S. mansoni infection,10 possible confounding factors such as concomitant 339 
infections and nutritional status of the children were not assessed during this study. 27 The 340 
study was not adequately powered to assess for a relationship between schistosomiasis and 341 
periportal fibrosis, and the low number of study participants with fibrotic changes should be 342 
taken into consideration when interpreting statistical analyses. Interpretation of results is made 343 
harder as many of these children received praziquantel approximately 12 months prior to this 344 
study, but these specific individuals are not known. Population numbers and characteristics 345 
are not well recorded in this area and investigation of this was beyond the scope of our study.  346 
This however meant that the data could not be adjusted according to population density for 347 
each village and limited our ability to understand the effect of the sociodemographic 348 
characteristics of the participants’ families on the results. Finally, misclassification of children 349 
14 
with or without periportal fibrosis may have skewed the data in either direction, though the 350 
93% accuracy in quality assurance is reassuring. 351 
 352 
Conclusion 353 
A high prevalence of periportal fibrosis has been detected amongst children as young 354 
as six years old in the Marolambo District, an area with a 98% prevalence of Schistosoma 355 
mansoni infection. This is of global relevance as it may reflect similarly remote areas of 356 
endemic countries which have not yet been studied and reinforces the importance of including 357 
hard-to-reach areas in surveys for a true understanding of disease burden. We present a 358 
method of using ultrasound to examine children in a particularly remote area that we hope 359 
could be reproduced in other regions in need of morbidity surveys and outreach work. 360 
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